Patient Information Leaflet
Brivaracetam Sandoz 25 mg film-coated tablets EFG
Brivaracetam Sandoz 50 mg film-coated tablets EFG
Brivaracetam Sandoz 75 mg film-coated tablets EFG
Brivaracetam Sandoz 100 mg film-coated tablets EFG
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Keep this leaflet, as you may need to read it again.
Contents of the leaflet
What is Brivaracetam Sandoz
Brivaracetam Sandoz contains the active substance brivaracetam. It belongs to a group of medications called "antiepileptics". These medications are used to treat epilepsy.
What is Brivaracetam Sandoz used for
Do not take Brivaracetam Sandoz:
Warnings and precautions
Consult your doctor or pharmacist before starting to take brivaracetam:
Children
Brivaracetam is not recommended for use in children under 2 years of age.
Other medications and Brivaracetam Sandoz
Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medications.
In particular, tell your doctor if you are taking any of the following medications, as your doctor may need to adjust your brivaracetam dose:
Taking Brivaracetam Sandoz with alcohol
Pregnancy and breastfeeding
Women of childbearing age should discuss the use of contraceptives with their doctor.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
It is not recommended to take brivaracetam if you are pregnant, as the effects of brivaracetam on pregnancy and the fetus are unknown.
It is not recommended to breastfeed your baby while taking brivaracetam, as brivaracetam is excreted in breast milk.
Do not stop treatment without consulting your doctor first. Stopping treatment may increase the number of seizures you have and harm your baby.
Driving and using machines
Brivaracetam Sandoz contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".
Follow your doctor's instructions for taking this medication exactly. If you are unsure, consult your doctor or pharmacist again. Other forms of this medication may be more suitable for some patients, e.g., children (if they cannot swallow whole tablets, for example). Consult your doctor or pharmacist.
You will take brivaracetam in combination with other medications to treat epilepsy.
How much to take
Your doctor will calculate the correct daily dose for you. Take the daily dose divided into two equal doses, approximately 12 hours apart.
Adolescents and children weighing 50 kg or more, and adults
Adolescents and children weighing between 20 kg and less than 50 kg
Children weighing between 10 kg and less than 20 kg
Patient with liver problems
If you have liver problems:
How to take Brivaracetam Sandoz tablets
Duration of treatment with Brivaracetam
Brivaracetam is a long-term treatment. Continue taking brivaracetam until your doctor tells you to stop.
If you take more Brivaracetam Sandoz than you should
If you take more brivaracetam than you should, consult your doctor. You may feel dizzy and drowsy. You may also experience some of the following symptoms: feeling unwell, feeling like you are spinning, balance problems, anxiety, feeling very tired, irritability, aggression, difficulty sleeping, depression, thoughts or attempts to harm yourself or commit suicide.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Brivaracetam
If you stop taking Brivaracetam
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them.
Very common:may affect more than 1 in 10 people.
Common:may affect up to 1 in 10 people.
Uncommon:may affect up to 1 in 100 people
Frequency not known:the frequency cannot be estimated from the available data
Other side effects in children
Common:may affect up to 1 in 10 people.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the carton and blister after CAD or EXP. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of via wastewater or household waste. Return the packaging and any unused medication to the pharmacy's SIGRE collection point. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Brivaracetam
Each Brivaracetam Sandoz 50 mg film-coated tablet contains 50 mg of brivaracetam.
Each Brivaracetam Sandoz 75 mg film-coated tablet contains 75 mg of brivaracetam.
Each Brivaracetam Sandoz 100 mg film-coated tablet contains 100 mg of brivaracetam.
The other components (excipients) are:
Brivaracetam Sandoz 25 mg tablets also contain: black iron oxide (E172) and yellow iron oxide (E172).
Brivaracetam Sandoz 50 mg tablets also contain: yellow iron oxide (E172).
Brivaracetam Sandoz 75 mg tablets also contain: black iron oxide (E172) and red iron oxide (E172).
Brivaracetam Sandoz 100 mg tablets also contain: yellow iron oxide (E172) and black iron oxide (E172).
Appearance of the product and package contents
Brivaracetam Sandoz 25 mg tablets are film-coated, gray, oblong, biconvex, and have "25" engraved on one side and are flat on the other.
Brivaracetam Sandoz 50 mg tablets are film-coated, yellow, oblong, biconvex, and have "50" engraved on one side and are flat on the other.
Brivaracetam Sandoz 75 mg tablets are film-coated, purple, oblong, biconvex, and have "75" engraved on one side and are flat on the other.
Brivaracetam Sandoz 100 mg tablets are film-coated, green, oblong, biconvex, and have "100" engraved on one side and are flat on the other.
Brivaracetam Sandoz is marketed in packs with aluminum-OPA/Al/PVC blisters of 14 or 56 film-coated tablets or in multiple packs containing 168 (3 packs of 56) film-coated tablets or in single-dose blisters of 14x1 or 56x1 film-coated tablets or in multiple packs containing 168 (3 packs of 56x1) film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble,
C/Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
PharOS MT Ltd.
HF62X, Hal Far Industrial Estate
Birzebbugia BBG3000
Malta
Or
PharOS Pharmaceutical Oriented Services Ltd.
Lesvou Street End, Thesi Loggos Industrial Zone
Metamorfossi, 14452
Greece
Or
Lek Pharmaceuticals d.d.
Verovškova ulica 57
1526 Ljubljana
Slovenia
This medication is authorized in the Member States of the European Economic Area under the following names:
Hungary: Brivaracetam Sandoz 10mg filmtabletta
Brivaracetam Sandoz 25mg filmtabletta
Brivaracetam Sandoz 50mg filmtabletta
Brivaracetam Sandoz 75mg filmtabletta
Brivaracetam Sandoz 100mg filmtabletta
Czech Republic: Brivaracetam Sandoz
Germany: Brivaracetam - 1 A Pharma 10 mg Filmtabletten
Brivaracetam - 1 A Pharma 25 mg Filmtabletten
Brivaracetam - 1 A Pharma 50 mg Filmtabletten
Brivaracetam - 1 A Pharma 75 mg Filmtabletten
Brivaracetam - 1 A Pharma 100 mg Filmtabletten
Denmark: Brivaracetam Sandoz
Greece: Brivaracetam/Sandoz
Spain: Brivaracetam Sandoz 25 mg film-coated tablets EFG
Brivaracetam Sandoz 50 mg film-coated tablets EFG
Brivaracetam Sandoz 75 mg film-coated tablets EFG
Brivaracetam Sandoz 100 mg film-coated tablets EFG
Italy: Brivaracetam Sandoz
Netherlands: Brivaracetam Sandoz 25 mg, filmomhulde tabletten
Brivaracetam Sandoz 50 mg, filmomhulde tabletten
Brivaracetam Sandoz 75 mg, filmomhulde tabletten
Brivaracetam Sandoz 100 mg, filmomhulde tabletten
Date of the last revision of this leaflet: February 2025
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/